Julie Harmon
Physician Assistant · Calhoun, GANPI 1013474733
Payments from drug & device makers
Across 163 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$251
- Lilly USA, LLC$204
- Pfizer$193
- Bayer$180
- Boehringer Ingelheim$170
- Novo Nordisk$152
- plus $2K from 34 others
What the payments were for
- Food & beverage$2,66897%
- Education$753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $251 |
| Lilly USA, LLC | 15 | $204 |
| Pfizer | 9 | $193 |
| Bayer | 9 | $180 |
| Boehringer Ingelheim | 10 | $170 |
| Novo Nordisk | 8 | $152 |
| Novartis | 5 | $121 |
| Gilead | 3 | $114 |
| Merck | 3 | $95 |
| Dexcom, Inc. | 5 | $90 |
| Amgen | 6 | $87 |
| Xeris Pharmaceuticals, Inc. | 5 | $80 |
| Daiichi Sankyo Inc. | 4 | $75 |
| AstraZeneca | 5 | $73 |
| GSK | 4 | $68 |
| Exact Sciences | 4 | $62 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
| Eisai Inc. | 3 | $54 |
| Abbott | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Rigel Pharmaceuticals, Inc. | 2 | $44 |
| Sanofi | 2 | $42 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Cranial Technologies, Inc | 2 | $34 |
| Coherus Oncology, Inc. | 1 | $29 |
| Organogenesis Inc. | 1 | $29 |
| Puma Biotechnology, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Beone Medicines USA, Inc. | 1 | $21 |
| Beigene USA, Inc. | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Servier Pharmaceuticals LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Exelixis Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $12 |
How this compares
$2,743 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $26,982 |
| FarxigaDapagliflozin Propanediol | 28 | $20,597 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $15,534 |
| JardianceEmpagliflozin | 19 | $14,470 |
| LinzessLinaclotide | 14 | $11,609 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $1,515 |
| Gabapentin | 74 | $1,480 |
| Levothyroxine Sodium | 68 | $996 |
| Omeprazole | 48 | $704 |
| Bupropion XlBupropion Hcl | 23 | $526 |
| Atorvastatin Calcium | 67 | $485 |
| Tizanidine Hcl | 44 | $419 |
| Fluticasone Propionate | 31 | $386 |
| Propranolol Hcl | 26 | $382 |
| Escitalopram Oxalate | 27 | $367 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $193 | $26,98226 claims |
| AstraZenecaFarxiga | $73 | $20,59728 claims |
| GSKTrelegy Ellipta | $68 | $15,53418 claims |
| Boehringer IngelheimJardiance | $170 | $14,47019 claims |
| AbbVieLinzess | $251 | $11,60914 claims |
| Almatica Pharma LLCSertraline Hcl | $12 | $35051 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Calhoun
- Joseph LangshawCalhoun$887K
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.